MedPath

Variation of Progesterone in IVF Cycles

Completed
Conditions
Progesterone Resistance
Registration Number
NCT03519776
Lead Sponsor
ART Fertility Clinics LLC
Brief Summary

to examine if a natural daytime variation in progesterone levels may explain parts of the inconsistent findings from studies reporting divergent results concerning this matter and will be carried out by several blood samples from the same patient during the day of ovulation triggering.

Detailed Description

The impact of the progesterone level at the end of the follicular phase in stimulated IVF/ICSI cycles and its effect on the pregnancy rate and oocyte quality is controversial, which arises from conflicting results in retrospective studies and meta-analyses. This study is assumed to examine if a natural daytime variation in progesterone levels may explain parts of the inconsistent findings from studies reporting divergent results concerning this matter and will be carried out by several blood samples from the same patient during the day of ovulation triggering. If variation is present, the impact of variation on the developing oocyte and embryo quality will be estimated by embryo quality indicators.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
30
Inclusion Criteria
  • patients 18-45 years
  • BMI 18-35 kg/m2
  • Menstrual cycle length 24-35 days
  • Stimulation with rFSH or hMG
Exclusion Criteria
  • None

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The variation of serum progesterone around the ovulation triggering in IVF-cycles6-8 months

the circadian secretion-pattern of progesterone during early follicular phase of normal cycling females

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

IVI Middle East Fertilty Clinic

🇦🇪

Abu Dhabi, United Arab Emirates

© Copyright 2025. All Rights Reserved by MedPath